Rules-based Volumetric Segmentation of Multiparametric MRI for Response Assessment in Recurrent High-Grade Glioma

Harshan Ravi1, Samuel H Hawkins1, Olya Stringfield1

  • 1Moffitt Cancer Center.

Research Square
|October 4, 2023
PubMed

Insights

Domain knowledge-based rules accurately segment brain tumor tissues in multiparametric MRI (mpMRI). This method enables quantitative assessment for clinical trials, predicting progression in recurrent high-grade glioma (rHGG).

Area of Science:

  • Radiology and Medical Imaging
  • Oncology
  • Artificial Intelligence in Medicine

Background:

  • Accurate segmentation of brain tumor subregions in multiparametric MRI (mpMRI) is crucial for treatment response assessment.
  • Current segmentation methods may lack consistency and interpretability, particularly in complex cases like high-grade glioma (HGG) and recurrent HGG (rHGG).
  • Quantitative analysis of tumor components is essential for evaluating treatment efficacy in clinical trials.

Approach:

  • Developed domain knowledge-based rules to assign voxels to distinct tissue types (e.g., contrast-enhancing tumor, edema) using mpMRI data.
  • Validated segmentation rules on external datasets and assessed their correlation with ground truth tumor and edema volumes.
  • Integrated rule-based tissue volumes into a predictive model for disease progression in a clinical trial of recurrent high-grade glioma (rHGG).

Key Points:

  • Rule-based segmentation of contrast-enhancing tumor (CE) and peritumoral edema (High FLAIR) showed strong correlation with ground truth volumes (R=0.85 and R=0.87, respectively).
  • A model combining treatment time and rule-based volumes achieved 82.5% accuracy in predicting progression within 30 days for rHGG patients.
  • The explainable decision tree approach provides validated and consistent intratumoral tissue volumes.

Conclusions:

  • Domain knowledge-based rules provide a validated and consistent method for segmenting brain tumor tissues on mpMRI.
  • This approach enables reliable quantitative assessment of tumor components, crucial for monitoring treatment response.
  • The developed method shows promise for predicting clinical progression in rHGG patients within clinical trial settings.

Related Concept Videos